RS
MRNA icon

Rakuten Securities’s Moderna MRNA Stock Holding History

Rakuten Securities’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Sell
3,543
-910
-20% -$47.1K 0.06% 128
2026
Q1 		$226K Buy
4,453
+907
+26% +$42.3K 0.09% 118
2025
Q4 		$105K Sell
3,546
-18,114
-84% -$492K 0.03% 171
2025
Q3 		$559K Sell
21,660
-647
-3% -$18K 0.21% 65
2025
Q2 		$615K Sell
22,307
-3,853
-15% -$101K 0.24% 60
2025
Q1 		$742K Buy
26,160
+18,661
+249% +$662K 0.37% 40
2024
Q4 		$312K Buy
7,499
+6,558
+697% +$313K 0.12% 81
2024
Q3 		$62.9K Buy
941
+778
+477% +$71.4K 0.03% 169
2024
Q2 		$19.4K Sell
163
-290
-64% -$36.7K 0.01% 264
2024
Q1 		$48.3K Sell
453
-626
-58% -$63.1K 0.02% 187
2023
Q4 		$107K Buy
+1,079
New +$90.8K 0.08% 118

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Rakuten Securities's MRNA Position: Q2 2026 in Review

Rakuten Securities reduced its Moderna (MRNA) stake by 20% in Q2 2026, selling an estimated $47.1K and leaving 3,543 shares worth $248K. The position accounts for 0.06% of the portfolio, ranked #128.

Rakuten Securities first reported a position in MRNA in Q4 2023 and has held it in 11 quarters since. The position peaked at $742K in Q1 2025. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Rakuten Securities held 3,543 shares of Moderna worth $248K as of Q2 2026.
  • Rakuten Securities sold 910 Moderna shares in Q2 2026, an estimated $47.1K.
  • Moderna made up 0.06% of Rakuten Securities's portfolio in Q2 2026, its #128 holding.
  • Rakuten Securities first reported a position in Moderna in Q4 2023 and has held it in 11 quarters since.
  • Rakuten Securities's Moderna position peaked at $742K in Q1 2025.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.